<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>As a class of bacteria, mycobacteria other than tuberculosis (MOTT), also known as nontuberculosis mycobacteria (NTM), affect both immunocompetents and immunodeficients. Nonspecific clinical symptoms caused by these bacteria include respiratory diseases, which often results in delayed diagnosis. This article discusses the spread, diagnosis, symptoms, and treatment of MOTT in the world. In view of the fact that NTM are prevalent in the environment, their isolation from the upper respiratory system of the respiratory tract does not necessarily indicate an active infection. To make an accurate diagnosis, clinical, radiographic, and microbiological factors must be considered. Clinical symptoms of NTM infection can be difficult to diagnose, even for experienced clinicians, due to their similarity to Mycobacterium tuberculosis infection. Based on the determined antibiogram, targeted treatment can be selected based on identification and drug susceptibility of the microorganism. There are a variety of therapeutic options, depending on the pathogen’s growth rate. However, it is always important to keep in mind the side effects of the drugs used and to choose the best treatment based on the individual patient’s clinical condition.</p>
</abstract>

As a class of bacteria, mycobacteria other than tuberculosis (MOTT), also known as nontuberculosis mycobacteria (NTM), affect both immunocompetents and immunodeficients. Nonspecific clinical symptoms caused by these bacteria include respiratory diseases, which often results in delayed diagnosis. This article discusses the spread, diagnosis, symptoms, and treatment of MOTT in the world. In view of the fact that NTM are prevalent in the environment, their isolation from the upper respiratory system of the respiratory tract does not necessarily indicate an active infection. To make an accurate diagnosis, clinical, radiographic, and microbiological factors must be considered. Clinical symptoms of NTM infection can be difficult to diagnose, even for experienced clinicians, due to their similarity to Mycobacterium tuberculosis infection. Based on the determined antibiogram, targeted treatment can be selected based on identification and drug susceptibility of the microorganism. There are a variety of therapeutic options, depending on the pathogen’s growth rate. However, it is always important to keep in mind the side effects of the drugs used and to choose the best treatment based on the individual patient’s clinical condition.

Mycobacteria other than tuberculosis – prevalence, symptoms, diagnostics and treatment

Department of General, Oncological and Reconstructive Surgery

Pomeranian Medical University in Szczecin Hospital No. 1

Department of Anaesthesiology and Intensive Care

Department of Paediatrics, Pediatric Nephrology, Dialysis and Acute Poisoning Treatment

Department of Paediatrics Neurosurgery and Neurosurgery

Independent Public Provincial Complex Hospital, Hospital Emergency Department

Pomeranian Journal of Life Sciences

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

As a class of bacteria, mycobacteria other than tuberculosis (MOTT), also known as nontuberculosis mycobacteria (NTM), affect both immunocompetents and...

Mycobacteria other than tuberculosis – prevalence, symptoms, diagnostics and treatment

Data publikacji: 08 paź 2023

Zakres stron: 48 - 51

DOI: https://doi.org/10.21164/pomjlifesci.933

Słowa kluczowe
mycobacteria other than tuberculosis, tuberculosis pneumonia, nontuberculosis mycobacteria, tuberculosis treatment

© 2023 Marcin Kołodziej et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mycobacteria other than tuberculosis – prevalence, symptoms, diagnostics and treatment

Data publikacji: 08 paź 2023

Zakres stron: 48 - 51

DOI: https://doi.org/10.21164/pomjlifesci.933

Słowa kluczowemycobacteria other than tuberculosis, tuberculosis pneumonia, nontuberculosis mycobacteria, tuberculosis treatment

© 2023 Marcin Kołodziej et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Słowa kluczowe
mycobacteria other than tuberculosis, tuberculosis pneumonia, nontuberculosis mycobacteria, tuberculosis treatment